Gandjbakhch, Estelle

2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias

Mach, F., Koskinas, K. C., Roeters van Lennep, J. E., Tokgözoğlu, L., Badimon, L., Baigent, C., Benn, M., Binder, C. J., Catapano, A. L., De Backer, G. G., et al. (2025) · European Heart Journal

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 688

Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis

Salem, J.-E., Bretagne, M., Abbar, B., Leonard-Louis, S., Ederhy, S., Redheuil, A., Boussouar, S., Nguyen, L. S., Procureur, A., Stein, F., et al. (2023) · Cancer Discovery

Cancer Immunotherapy and BiomarkersInflammatory Myopathies and Dermatomyositis

Cited by 243

Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database

Nguyen, L. S., Cooper, L. T., Kerneis, M., Funck-Brentano, C., Silvain, J., Brechot, N., Hekimian, G., Ammirati, E., Ben M’Barek, B., Redheuil, A., et al. (2022) · Nature Communications

Pharmacovigilance and Adverse Drug ReactionsViral Infections and Immunology Research

Cited by 136

Effect of Intracoronary Administration of AAV1/SERCA2a on Ventricular Remodelling in Patients with Advanced Systolic Heart Failure: Results from the Agent-Hf Randomized Phase 2 Trial

Hulot, J.-S., Salem, J.-E., Redheuil, A., Collet, J.-P., Varnous, S., Jourdain, P., Logeart, D., Gandjbakhch, E., Bernard, C., Hatem, S. N., et al. (2017) · European Journal of Heart Failure

Virus-based gene therapy researchCardiac Fibrosis and Remodeling

Cited by 113

Localized structural alterations underlying a subset of unexplained sudden cardiac death

Haïssaguerre, M., Hocini, M., Cheniti, G., Duchateau, J., Sacher, F., Puyo, S., Cochet, H., Takigawa, M., Denis, A., Martin, R., et al. (2018) · Circulation: Arrhythmia and Electrophysiology

Cardiac electrophysiology and arrhythmiasCardiac Arrhythmias and Treatments

Cited by 96

High Risk of Heart Failure Associated with Desmoglein-2 Mutations Compared to Plakophilin-2 Mutations in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia

Hermida, A., Fressart, V., Hidden-Lucet, F., Donal, E., Probst, V., Deharo, J.-C., Chevalier, P., Klug, D., Mansencal, N., Delacretaz, E., et al. (2019) · European Journal of Heart Failure

Cardiovascular Effects of ExerciseCardiomyopathy and Myosin Studies

Cited by 71

Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants

Gasperetti, A., Muller, S. A., Peretto, G., Asatryan, B., Protonotarios, A., Laredo, M., Tarlet, P.-Y., Syrris, P., Carrick, R. T., Murray, B., et al. (2025) · Circulation

Viral Infections and Immunology ResearchCardiomyopathy and Myosin Studies

Cited by 36

Long-Term Follow-Up Data on Flecainide Use as an Antiarrhythmic in Arrhythmogenic Right Ventricular Cardiomyopathy

Gaine, S., Rolland, T., Asatryan, B., Laredo, M., Sampognaro, J., Carrick, R. T., Peretto, G., Muller, S., Villatore, A., Murray, B., et al. (2025) · JACC: Clinical Electrophysiology

Cardiovascular Effects of ExerciseCardiac electrophysiology and arrhythmias

Cited by 14